VIVICELLS INTERNATIONAL INC

VIVICELLS INTERNATIONAL INC

OOTC:VCII
0.00
USD
0.00
(0.00%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
Kevin Day
Full Time Employees
16
Sector
Consumer non-durables
Industry
Beverages: non-alcoholic
Address
2142 Ashland Avenue St. Petersburg IL United States 60201
IPO Date
Jan 27, 1998
Business
ViviCells International, Inc. (VCII) operates as a stem cell preservation company in the healthcare sector. The company provides stem cell collection, processing, cryopreservation, and storage services; it focuses on preserving hematopoietic stem cells from umbilical cord blood for potential therapeutic use in treating degenerative diseases and supporting regenerative medicine applications. Incorporated in 1995 and headquartered at 2142 Ashland Avenue, Suite 2, Evanston, Illinois, United States, ViviCells targets families and healthcare providers primarily in the U.S. market with its biotechnology solutions. Previously known as Tropical Beverage Inc., the company changed its name to ViviCells International, Inc. in May 2008 to reflect its pivot to stem cell preservation activities. Recent financial data indicates trailing twelve-month revenue of US$5.09 million as of the last reported period, though no major partnerships, acquisitions, funding rounds, or new product launches have been publicly disclosed within the past 1-2 years; the firm maintains a micro-cap market value of approximately US$23,000 and trades on OTCPK.